Published in PLoS One on April 15, 2013
Reliable genotypic tropism tests for the major HIV-1 subtypes. Sci Rep (2015) 0.87
HIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants. PLoS One (2014) 0.81
HIV coreceptor tropism determination and mutational pattern identification. Sci Rep (2016) 0.81
IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform. PLoS Comput Biol (2014) 0.76
An in silico platform for predicting, screening and designing of antihypertensive peptides. Sci Rep (2015) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Sequence logos: a new way to display consensus sequences. Nucleic Acids Res (1990) 36.74
ROCR: visualizing classifier performance in R. Bioinformatics (2005) 19.60
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol (1999) 13.55
Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics (2000) 11.75
Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol (1992) 7.92
Structure of a V3-containing HIV-1 gp120 core. Science (2005) 7.69
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother (2005) 7.42
The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med (1996) 5.46
Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol (1992) 4.86
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol (2003) 4.56
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother (2006) 4.14
Prediction of protein structural classes. Crit Rev Biochem Mol Biol (1995) 3.90
The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (2004) 3.75
Bioinformatics prediction of HIV coreceptor usage. Nat Biotechnol (2007) 3.64
Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 3.42
V3: HIV's switch-hitter. AIDS Res Hum Retroviruses (2005) 3.00
Two Sample Logo: a graphical representation of the differences between two sets of sequence alignments. Bioinformatics (2006) 3.00
Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med (2011) 2.98
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol (2002) 2.90
Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology (2001) 2.74
ESLpred: SVM-based method for subcellular localization of eukaryotic proteins using dipeptide composition and PSI-BLAST. Nucleic Acids Res (2004) 2.72
Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther (2007) 2.49
Prediction of RNA binding sites in a protein using SVM and PSSM profile. Proteins (2008) 2.40
Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol (2002) 2.19
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol (2007) 2.14
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol (2006) 2.05
Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J Virol (2006) 2.00
A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses (2003) 1.92
Support vector machine-based method for subcellular localization of human proteins using amino acid compositions, their order, and similarity search. J Biol Chem (2005) 1.85
Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J Virol (2001) 1.79
Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Microbiol (1995) 1.79
The HIV coreceptor switch: a population dynamical perspective. Trends Microbiol (2005) 1.76
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein. J Virol (2008) 1.43
Pathogenesis of macrophage tropic HIV-1. Curr HIV Res (2005) 1.43
Prediction of mitochondrial proteins using support vector machine and hidden Markov model. J Biol Chem (2005) 1.42
Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput Biol (2007) 1.39
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol (2000) 1.39
Classification of nuclear receptors based on amino acid composition and dipeptide composition. J Biol Chem (2004) 1.36
Prediction of co-receptor usage of HIV-1 from genotype. PLoS Comput Biol (2010) 1.29
Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. J Clin Virol (2009) 1.24
Prediction of protein secondary structure content by using the concept of Chou's pseudo amino acid composition and support vector machine. Protein Pept Lett (2009) 1.20
Genotypic prediction of HIV-1 subtype D tropism. Retrovirology (2011) 1.16
Correlation and prediction of gene expression level from amino acid and dipeptide composition of its protein. BMC Bioinformatics (2005) 1.16
Identification of ATP binding residues of a protein from its primary sequence. BMC Bioinformatics (2009) 1.15
Current tests to evaluate HIV-1 coreceptor tropism. Curr Opin HIV AIDS (2009) 1.12
Prediction of cell wall lytic enzymes using Chou's amphiphilic pseudo amino acid composition. Protein Pept Lett (2009) 1.08
HIV-1 coreceptor usage prediction without multiple alignments: an application of string kernels. Retrovirology (2008) 1.05
HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors. Biochim Biophys Acta (2003) 1.02
Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues. AIDS Res Hum Retroviruses (2008) 1.00
Prediction of GTP interacting residues, dipeptides and tripeptides in a protein from its evolutionary information. BMC Bioinformatics (2010) 0.99
Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology (2001) 0.97
Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol (2007) 0.97
Prediction of R5, X4, and R5X4 HIV-1 coreceptor usage with evolved neural networks. IEEE/ACM Trans Comput Biol Bioinform (2008) 0.95
Drug safety evaluation of maraviroc for the treatment of HIV infection. Expert Opin Drug Saf (2011) 0.95
Improved prediction of HIV‐1 coreceptor usage with sequence information from the second hypervariable loop of gp120. J Infect Dis (2010) 0.92
Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype B. Antimicrob Agents Chemother (2011) 0.92
Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage. Retrovirology (2011) 0.91
Prediction of nuclear proteins using SVM and HMM models. BMC Bioinformatics (2009) 0.90
Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor. J Mol Evol (2004) 0.84
Robust supervised and unsupervised statistical learning for HIV type 1 coreceptor usage analysis. AIDS Res Hum Retroviruses (2009) 0.83
Analysis and prediction of cancerlectins using evolutionary and domain information. BMC Res Notes (2011) 0.82
Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage. BMC Bioinformatics (2010) 0.81
HIV-1 CRF01_AE coreceptor usage prediction using kernel methods based logistic model trees. Comput Biol Med (2012) 0.78
Poor performance of bioinformatics programs for genotypic prediction of coreceptor usage of HIV-1 group O isolates. J Acquir Immune Defic Syndr (2010) 0.77
Determination of co-receptor usage of HIV-1. Methods Mol Biol (2005) 0.76
Bcipep: a database of B-cell epitopes. BMC Genomics (2005) 2.27
Support vector machine-based method for subcellular localization of human proteins using amino acid compositions, their order, and similarity search. J Biol Chem (2005) 1.85
Identification of DNA-binding proteins using support vector machines and evolutionary profiles. BMC Bioinformatics (2007) 1.59
Prediction of mitochondrial proteins using support vector machine and hidden Markov model. J Biol Chem (2005) 1.42
MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes. BMC Res Notes (2009) 1.41
Classification of nuclear receptors based on amino acid composition and dipeptide composition. J Biol Chem (2004) 1.36
Improved method for linear B-cell epitope prediction using antigen's primary sequence. PLoS One (2013) 1.34
In silico platform for prediction of N-, O- and C-glycosites in eukaryotic protein sequences. PLoS One (2013) 1.29
In silico approaches for designing highly effective cell penetrating peptides. J Transl Med (2013) 1.17
AntiBP2: improved version of antibacterial peptide prediction. BMC Bioinformatics (2010) 1.15
Identification of ATP binding residues of a protein from its primary sequence. BMC Bioinformatics (2009) 1.15
SVM based prediction of RNA-binding proteins using binding residues and evolutionary information. J Mol Recognit (2011) 1.13
NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database. Nucleic Acids Res (2012) 1.11
Branching of the p-nitrophenol (PNP) degradation pathway in burkholderia sp. Strain SJ98: Evidences from genetic characterization of PNP gene cluster. AMB Express (2012) 1.10
TumorHoPe: a database of tumor homing peptides. PLoS One (2012) 1.07
ESLpred2: improved method for predicting subcellular localization of eukaryotic proteins. BMC Bioinformatics (2008) 1.07
Identification of NAD interacting residues in proteins. BMC Bioinformatics (2010) 1.07
Prediction methods for B-cell epitopes. Methods Mol Biol (2007) 1.05
In silico approach for predicting toxicity of peptides and proteins. PLoS One (2013) 1.02
Prediction of polyadenylation signals in human DNA sequences using nucleotide frequencies. In Silico Biol (2009) 1.00
Prediction of guide strand of microRNAs from its sequence and secondary structure. BMC Bioinformatics (2009) 0.99
Prediction of GTP interacting residues, dipeptides and tripeptides in a protein from its evolutionary information. BMC Bioinformatics (2010) 0.99
Application of machine learning techniques in predicting MHC binders. Methods Mol Biol (2007) 0.99
BTXpred: prediction of bacterial toxins. In Silico Biol (2007) 0.98
Prediction and classification of ncRNAs using structural information. BMC Genomics (2014) 0.97
Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res (2013) 0.96
RSLpred: an integrative system for predicting subcellular localization of rice proteins combining compositional and evolutionary information. Proteomics (2009) 0.96
Prediction of FAD interacting residues in a protein from its primary sequence using evolutionary information. BMC Bioinformatics (2010) 0.96
CancerDR: cancer drug resistance database. Sci Rep (2013) 0.96
Machine learning techniques in disease forecasting: a case study on rice blast prediction. BMC Bioinformatics (2006) 0.95
KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials. BMC Bioinformatics (2010) 0.93
GlycoPP: a webserver for prediction of N- and O-glycosites in prokaryotic protein sequences. PLoS One (2012) 0.93
A machine learning based method for the prediction of secretory proteins using amino acid composition, their order and similarity-search. In Silico Biol (2008) 0.93
Identification of mannose interacting residues using local composition. PLoS One (2011) 0.92
Computational approach for designing tumor homing peptides. Sci Rep (2013) 0.92
HIVsirDB: a database of HIV inhibiting siRNAs. PLoS One (2011) 0.91
ccPDB: compilation and creation of data sets from Protein Data Bank. Nucleic Acids Res (2011) 0.90
Prediction of neurotoxins based on their function and source. In Silico Biol (2007) 0.90
Designing of highly effective complementary and mismatch siRNAs for silencing a gene. PLoS One (2011) 0.90
Prediction of nuclear proteins using SVM and HMM models. BMC Bioinformatics (2009) 0.90
PRRDB: a comprehensive database of pattern-recognition receptors and their ligands. BMC Genomics (2008) 0.90
CyclinPred: a SVM-based method for predicting cyclin protein sequences. PLoS One (2008) 0.89
Hmrbase: a database of hormones and their receptors. BMC Genomics (2009) 0.88
PHDcleav: a SVM based method for predicting human Dicer cleavage sites using sequence and secondary structure of miRNA precursors. BMC Bioinformatics (2013) 0.88
A simple approach for predicting protein-protein interactions. Curr Protein Pept Sci (2010) 0.88
COPid: composition based protein identification. In Silico Biol (2008) 0.87
OxDBase: a database of oxygenases involved in biodegradation. BMC Res Notes (2009) 0.87
Designing of interferon-gamma inducing MHC class-II binders. Biol Direct (2013) 0.86
Prediction and classification of aminoacyl tRNA synthetases using PROSITE domains. BMC Genomics (2010) 0.86
A web server for predicting inhibitors against bacterial target GlmU protein. BMC Pharmacol (2011) 0.85
ProGlycProt: a repository of experimentally characterized prokaryotic glycoproteins. Nucleic Acids Res (2011) 0.85
Virtual Screening of potential drug-like inhibitors against Lysine/DAP pathway of Mycobacterium tuberculosis. BMC Bioinformatics (2010) 0.85
Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics. Brief Bioinform (2017) 0.84
Bridging innate and adaptive antitumor immunity targeting glycans. J Biomed Biotechnol (2010) 0.84
Open source software and web services for designing therapeutic molecules. Curr Top Med Chem (2013) 0.84
Searching and mapping of B-cell epitopes in Bcipep database. Methods Mol Biol (2007) 0.82
Prediction of vitamin interacting residues in a vitamin binding protein using evolutionary information. BMC Bioinformatics (2013) 0.80
Peptide toxicity prediction. Methods Mol Biol (2015) 0.79
BIAdb: a curated database of benzylisoquinoline alkaloids. BMC Pharmacol (2010) 0.79
In silico models for B-cell epitope recognition and signaling. Methods Mol Biol (2013) 0.79
PolysacDB: a database of microbial polysaccharide antigens and their antibodies. PLoS One (2012) 0.78
In silico platform for predicting and initiating β-turns in a protein at desired locations. Proteins (2015) 0.77
Development of a model webserver for breed identification using microsatellite DNA marker. BMC Genet (2013) 0.77
Searching and mapping of T-cell epitopes, MHC binders, and TAP binders. Methods Mol Biol (2007) 0.76
Predicting virulence factors of immunological interest. Methods Mol Biol (2007) 0.76
Intrinsic contributions of polar amino acid residues toward thermal stability of an ABC-ATPase of mesophilic origin. Protein Sci (2003) 0.75
Searching haptens, carrier proteins, and anti-hapten antibodies. Methods Mol Biol (2007) 0.75